Background The participation of clinical pharmacists in the treatment of acute pancreatitis has rarely been reported. Objective The aim of this study was to retrospectively evaluate the impact of intervention of clinical pharmacists on the treatment of acute pancreatitis. Setting An academic teaching hospital in Taizhou, Jiangsu, China. Method Two hundred and twenty-eight patients with acute pancreatitis were retrospectively enrolled from July 2017 to July 2018 and divided into an intervention group (n = 119) and a control group (n = 109) according to whether a clinical pharmacist was involved. No significant differences in the baseline clinical characteristics were found between the groups. Clinical pharmacists participated in drug formulation and adjustment, pharmaceutical care, and follow-up. Main outcome measure Clinical outcomes, average hospital stays, costs, incidence of adverse drug reactions, 1-month subsequent visit rate, and patient satisfaction between the two groups were measured. Results The clinical symptoms of patients in both groups were relieved after treatment. There were no significant differences between the groups in computed tomography grades after treatment, incidence of adverse drug reactions, or average hospital stays. However, the intervention group had lower total costs of hospitalization, drugs and antibiotics but higher rates of 1-month subsequent visits and satisfaction compared with the control group. Conclusion The intervention of clinical pharmacists in the treatment of acute pancreatitis can effectively reduce costs of hospitalization, drug and antibiotics and improve follow-up compliance and patient satisfaction.
Acute pancreatitis China Clinical pharmacist Pharmaceutical care Pharmacist intervention
This is a preview of subscription content, log in to check access.
We thank all the medical staff for their participation in this study.
This work was funded by the Guidance plan for social development of Taizhou Municipal Science and Technology (ssf20160141). The funder had no role in the study design, data collection, data analysis, data interpretation, writing of the report, decision to publish, or preparation of the manuscript.
van Dijk SM, Hallensleben NDL, van Santvoort HC, Fockens P, van Goor H, Bruno MJ, et al. Acute pancreatitis: recent advances through randomised trials. Gut. 2017;66(11):2024–32.CrossRefGoogle Scholar
Banks PA, Freeman ML. Practice guidelines in acute pancreatitis. Am J Gastroenterol. 2006;101(10):2379–400.CrossRefGoogle Scholar
Roberts SE, Morrison-Rees S, John A, Williams JG, Brown TH, Samuel DG. The incidence and aetiology of acute pancreatitis across Europe. Pancreatology. 2017;17(2):155–65.CrossRefGoogle Scholar
Bi Y, Atwal T, Vege SS. Drug therapy for acute pancreatitis. Curr Treat Options Gastroenterol. 2015;13(3):354–68.CrossRefGoogle Scholar
Yang P, Jiang SP, Lu XY. Effectiveness of continuous improvement by a clinical pharmacist-led guidance team on the prophylactic antibiotics usage rationality in intervention procedure at a Chinese tertiary teaching hospital. Ther Clin Risk Manag. 2017;13:469–76.CrossRefGoogle Scholar
Malfara M, Pernassi M, Aragon D, Carlotti A. Impact of the clinical pharmacist interventions on prevention of pharmacotherapy related problems in the paediatric intensive care unit. Int J Clin Pharm. 2018;40(3):513–9.CrossRefGoogle Scholar
Yang H, Li L, Hu X, Wang W, Yang X, Liu H, et al. Impact of pharmacist-led post-transplant medication management for kidney transplant recipients: a retrospective pre- and post-intervention study. J Clin Pharm Ther. 2019. CrossRefPubMedGoogle Scholar
Greenberg JA, Hsu J, Bawazeer M, Marshall J, Friedrich JO, Nathens A, et al. Clinical practice guideline: management of acute pancreatitis. Can J Surg J canadien de chirurgie. 2016;59(2):128–40.CrossRefGoogle Scholar
Raghuwanshi S, Gupta R, Vyas MM, Sharma R. CT evaluation of acute pancreatitis and its prognostic correlation with CT severity index. J Clin Diagn Res. 2016;10(6):TC6–11.Google Scholar
Bradley EL II. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11 through 13, 1992. Arch Surg (Chicago, Ill: 1960). 1993;128(5):586–90.CrossRefGoogle Scholar
Garcia-Barrasa A, Borobia FG, Pallares R, Jorba R, Poves I, Busquets J, et al. A double-blind, placebo-controlled trial of ciprofloxacin prophylaxis in patients with acute necrotizing pancreatitis. J Gastrointest Surg. 2009;13(4):768–74.CrossRefGoogle Scholar
Najafzadeh M, Schnipper JL, Shrank WH, Kymes S, Brennan TA, Choudhry NK. Economic value of pharmacist-led medication reconciliation for reducing medication errors after hospital discharge. Am J Manag Care. 2016;22(10):654–61.PubMedGoogle Scholar
Shayegani R, Pugh MJ, Kazanis W, Wilkening GL. Reducing coprescriptions of benzodiazepines and opioids in a veteran population. Am J Manag Care. 2018;24(8):e265–9.PubMedGoogle Scholar
Ahmed Ali U, Issa Y, Hagenaars JC, Bakker OJ, van Goor H, Nieuwenhuijs VB, et al. Risk of recurrent pancreatitis and progression to chronic pancreatitis after a first episode of acute pancreatitis. Clin Gastroenterol Hepatol. 2016;14(5):738–46.CrossRefGoogle Scholar
Yadav D, O’Connell M, Papachristou GI. Natural history following the first attack of acute pancreatitis. Am J Gastroenterol. 2012;107(7):1096–103.CrossRefGoogle Scholar
Lankisch PG, Breuer N, Bruns A, Weber-Dany B, Lowenfels AB, Maisonneuve P. Natural history of acute pancreatitis: a long-term population-based study. Am J Gastroenterol. 2009;104(11):2797–805.CrossRefGoogle Scholar
Busireddy KK, AlObaidy M, Ramalho M, Kalubowila J, Baodong L, Santagostino I, et al. Pancreatitis-imaging approach. World J Gastrointest Pathophysiol. 2014;5(3):252–70.CrossRefGoogle Scholar